Regeneron Pharmaceuticals, Inc.(REGN)NASDAQ
Fundamental Analysis & Financials
Valuation Snapshot
What the multiples imply about expectations
The market considers the company to be a mid-cap company with a significant market presence. At current multiples, it trades fairly valued—reflecting market expectations.
Valuation Metrics
Ratios and multiples
Financial Health
Liquidity and leverage
The company's financial health appears strong. High ROE and strong ROA reflect reasonably efficient capital use. Debt is elevated but represents structural leverage for shareholder return strategy (buybacks) rather than operational stress.
Valuation Multiples
Current valuation metrics
Quarterly Earnings History
Recent quarterly financial performance and trends
| Quarter | Revenue | Net Income | Gross Profit | EPS (Basic) | EPS (Diluted) | Gross Margin | Net Margin |
|---|---|---|---|---|---|---|---|
| Q2 2026(Latest) | $4.29B | $1.30B | $3.71B | $12.62 | $12.23 | 86.6% | 30.2% |
| Q1 2026 | $3.61B | $727.20M | $2.94B | $6.99 | $6.75 | 81.4% | 20.2% |
| Q4 2025 | $3.88B | $844.60M | $3.30B | $8.21 | $7.86 | 84.9% | 21.7% |
| Q3 2025 | $3.75B | $1.46B | $3.23B | $14.09 | $13.62 | 86.1% | 38.9% |
| Q2 2025 | $3.68B | $1.39B | $3.15B | $13.24 | $12.81 | 85.6% | 37.9% |
| Q1 2025 | $3.03B | $808.70M | $2.56B | $7.58 | $7.27 | 84.7% | 26.7% |
Key Insights:
- Revenue increased by 19.0% from previous quarter
- Net margin of 30.2% indicates strong profitability
- EPS improved by 81.2% quarter-over-quarter
Financial Efficiency
Utilization and collections performance
Asset Turnover 0.38 indicates low efficiency. Receivables Turnover 2.71 and DSO 134.89 reflect poor collections. Working Capital Turnover 1.14 is moderately efficient. ROIC 13.0% highlights moderate capital returns.
Efficiency Metrics
Profitability & Growth
Margins and earnings power
Efficiency Performance Matrix
4-quadrant analysis of operational efficiency vs profitability
Efficiency vs Profitability Quadrants
High Margin
Low Margin
High Margin
Low Margin
Efficiency Analysis
Asset Turnover
Receivables Turnover
Working Capital
Overall Efficiency Score
Profit-focused operations with efficiency opportunities
⚠️ Thresholds are benchmark-based heuristics derived from long-term industry averages, not strict valuation rules.
• Bubble size represents ROIC magnitude
• Green (Optimal): Excellent efficiency-profitability balance
• Blue (Efficiency-Driven): High turnover, room to improve margins
• Yellow (Margin-Driven): Strong margins, opportunity to improve efficiency
• Red (Weak Operations): Areas needing improvement on both dimensions
Market Data & Share Structure
Comprehensive valuation metrics and ownership breakdown
Market Data & Capitalization
Share Statistics & Ownership
Profitability Margin Pyramid
Hierarchical view of margin compression from revenue to net income
Margin Hierarchy by Profitability Level
Margin Analysis
Total Revenue
Gross Profit
EBITDA
Net Income
Margin Quality Assessment
Excellent margin structure with strong bottom-line profitability
• Larger circles represent higher dollar amounts
• Margin percentages show profitability at each level
• Blue: Revenue base
• Green: Gross profitability
• Yellow: Operating performance
• Red: Net profitability
Operating Cash & Liquidity
Core cash generation and short-term solvency
Cash Flow Analysis
Operating Cash Flow (TTM)
$4.68B
Cash from core operations
Free Cash Flow (TTM)
$3.07B
Available after capex
Financial Position & Liquidity
Current Ratio
3.33
Healthy
Quick Ratio
2.63
Strong
Net Cash
$5.29B
Net creditor
Total Cash
$7.99B
Balance sheet cash
Total Debt
$2.71B
Outstanding borrowings
Ownership & Shareholder Sentiment
Insider, institutional, and short interest positions
Insider Ownership
2.08%
Moderate stake
Institutional Ownership
93.83%
Majority backing
Short % of Float
359.00%
Heavy bearish
Short Ratio (Days)
3.6d
days to cover
Ownership structure shows limited insider stake and institutional majority backing.
Dividends & Shareholder Returns
Policy stance and implications
The company maintains a very sustainable dividend policy with a payout ratio of 9.0% (FCF coverage: 8.3x). Strong cash flow coverage supporting modest shareholder yield with ample room for sustainability.
Explore More Analysis for REGN
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.